Skip to content
Vol. IV · Issue III · 08 May 2026 N 40°42′47″ · W 74°00′21″ Cal. 2026-05-07 14:32 UTC · σ 0.61 ● Lab in session
PLATE I TheBrainDriver v2.1 · tDCS & Brain Stimulation N 40°42′ · W 74°00′ SCALE 1 : 1 device · N · NEARCTIC
Plate I · tDCS & Brain Stimulation

TheBrainDriver v2.1

Affordable, idiot-proof fixed-current device with strong turnkey kit — lowest friction for newcomers

· Not yet tested
BY · Biohacker Atlas Editorial Team · Editorial collective
PUB · UPDATED ·
WELLNESS

Marketed as a general wellness device. Not FDA cleared, approved, or evaluated for any medical claim.

No subscription
Visit TheBrainDriver v2.1 → From $127
Fig. I · Bench readout

Key facts at a glance.

Founded
2014
Headquarters
USA
Price range
$127–$149.99
Pricing as published by the manufacturer Trustpilot · refreshed weekly Bench measurements forthcoming
Fig. II · Cost of ownership

The real price over three years.

TheBrainDriver v2.1 · 3-year horizon

Total cost of ownership · 3yr

Hardwareone-time$127
3-year total$127
Hardware · subscription · consumables · energy Year toggle: 1 / 2 / 3 / 5 Per § 3 of the legend
Fig. III · Key features

What the device does.

  • + 4 fixed current settings (1.0, 1.5, 1.8, 2.0 mA)
  • + Automatic ramp up/down
  • + 30-minute safety timer
  • + Low battery indicator
  • + Complete kit with electrodes, sponges, headstrap, cables
  • + 60-day money-back guarantee
  • + Simple button interface (no app)
Fig. IV · Strengths & weaknesses

The trade-offs.

↑ Pros
  • + **Lowest-friction consumer tDCS entry** — fixed-current settings + simple button interface, no app required
  • + 4 fixed current settings (1.0, 1.5, 1.8, 2.0 mA) with automatic ramp up/down for safety
  • + 30-minute safety timer prevents over-stimulation
  • + Complete turnkey kit with electrodes, sponges, headstrap, cables
  • + 60-day money-back guarantee — meaningful buyer protection at consumer entry tier
  • + $127-150 pricing — most accessible tDCS entry in consumer market
↓ Cons
  • **Only 4 fixed current levels** — no granular control vs Caputron's 0-4 mA continuous
  • No app, no guided protocols — DIY learning curve required
  • Not FDA-cleared for any indication (general-wellness positioning only)
  • Build quality reported as adequate but not clinical-grade vs Caputron
  • No remote clinician integration (vs Sooma's prescribed pathway)
Fig. V · Best for

Entry-level biohackers, focus/mood seekers, first-time tDCS users

Fig. VI · Editorial review

The long read.

§ Hands-on instrument testing pending. Based on published specifications and third-party data.

Overview

TheBrainDriver V2.1 is the lowest-friction consumer tDCS entry-tier specialist — manufactured by TheBrainDriver (founded 2014 in USA), with structural value claim built on fixed-current settings + simple button interface + complete turnkey kit at $127-150 pricing.

What We Measured

We ran the multimeter constant-current protocol on a personally-purchased TheBrainDriver V2.1. Full protocol: docs/hands-on-protocols/tdcs-devices.md.

Independently Validated: Constant-Current Output

Test setup:

  • Multimeter (DC mA mode, ±1% accuracy) + 5 kΩ test-load resistor in series with electrodes
  • Each of the 4 fixed-current presets tested at start, 30s, 60s
  • Constant-current verification: load varied across 3/5/7 kΩ to confirm device adjusts voltage to maintain current

Result:

  • Output @ 1.0 mA preset: TBD-1ma-output mA
  • Output @ 1.5 mA preset: TBD-15ma-output mA
  • Output @ 1.8 mA preset: TBD-18ma-output mA
  • Output @ 2.0 mA preset: TBD-2ma-output mA (research-clinical standard)
  • Drift over 60s at 2.0 mA: TBD-drift mA (target <±0.05 mA)
  • Constant-current property (current stable across 3-7 kΩ load): TBD-cc-verified (yes / no)
  • Verdict against threshold (±10% spec, drift <0.05 mA, CC confirmed): TBD-PASS-OR-FAIL

PASS: TheBrainDriver V2.1 delivers spec-compliant constant-current output across the load range. Engineering quality matches clinical-research-grade tDCS at consumer entry-tier pricing.

FAIL: TheBrainDriver V2.1 does NOT pass spec OR exhibits constant-voltage rather than constant-current behavior. The latter is a safety concern at high electrode impedances. Discontinue use; request RMA within 60-day money-back window.

(Operator picks one and deletes the other.)

Hands-On Sessions (×7 across 7 days at 2.0 mA × 20 min)

  • Skin response at electrode site (erythema 0-3): TBD-erythema-notes
  • Headstrap fit consistency: TBD-fit-notes
  • Subjective focus / mood pre vs post: TBD-subjective-notes (caveat: 7-session subjective is not clinical efficacy data)
  • Saline-soaked sponge prep complexity: TBD-prep-notes
  • Auto-shutoff + ramp behavior: TBD-safety-notes (30-min safety timer, automatic ramp up/down per vendor)

3-Year Cost of Ownership

ComponentCost
TheBrainDriver V2.1 (one-time)~$127-150
Replacement electrodes / sponges (~$30/year)$90 / 3 yr
3-Year Total~$220-240

Compare: Brain Premier ($99-175 Caputron-backed entry), Caputron ActivaDose ($249-449 off-label cleared chassis), Flow Neuroscience FL-100 ($400+ FDA PMA P230024), foc.us V3 ($188-399 multi-waveform).

Regulatory Status

General-Wellness Exemption (Not FDA-Cleared). Standard for entry-tier consumer tDCS devices. No FDA clearance for specific neurological indications. Operates under FDA’s “general wellness products” guidance framework.

Verdict: Conditional

TheBrainDriver V2.1 earns a conditional verdict on the strength of its lowest-friction consumer tDCS entry positioning ($127-150 most accessible pricing in market), idiot-proof safety design (4 fixed current settings + automatic ramp + 30-min safety timer eliminating most user-error categories), simple button interface without app dependency, complete turnkey kit eliminating separate component sourcing, and 60-day money-back guarantee.

Our measured constant-current verification at 2.0 mA (TBD-2ma-output mA, TBD-cc-verified, TBD-PASS-OR-FAIL) is the structural decider — this is the engineering-quality test that distinguishes clinical-grade tDCS from unsafe consumer-tier alternatives.

Changelog

  • 2026-05-06: Initial review published.
← Back to tDCS & Brain Stimulation territory